[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345397-105":59,"doc-detail-345397-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evaluating-dna-methylation-markers-and-extended-hpv-genotyping-in-first-void-urine-for-detecting-high-grade-cervical-lesions-in-hpv-positive-women-a-cross-sectional-study-abstract","Evaluating DNA methylation markers and extended HPV genotyping in first-void urine for detecting high-grade cervical lesions in HPV-positive women - a cross-sectional study - Abstract","","This cross-sectional study evaluates DNA methylation markers ASCL1 and LHX8 in first-void urine (FVU) from HPV-positive women for detecting high-grade cervical disease, specifically CIN2+ and CIN3+. Paired FVU and clinician-collected cervical samples were analyzed to compare methylation performance with HPV genotyping, including extended HPV16/18/31/33/52. ASCL1/LHX8 methylation increased with disease severity, with diagnostic accuracy assessed by AUC, sensitivities, specificities, and logistic regression. Results support methylation testing as a complementary urine-based triage approach alongside HPV genotyping.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evaluating-dna-methylation-markers-and-extended-hpv-genotyping-in-first-void-urine-for-detecting-high-grade-cervical-lesions-in-hpv-positive-women-a-cross-sectional-study-abstract/345397/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evaluating-dna-methylation-markers-and-extended-hpv-genotyping-in-first-void-urine-for-detecting-high-grade-cervical-lesions-in-hpv-positive-women-a-cross-sectional-study-abstract/345397.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of testing ASCL1 and LHX8 methylation in first-void urine?","Question",{"text":112,"@type":113},"To evaluate the clinical performance of ASCL1 and LHX8 DNA methylation markers in HPV-positive first-void urine for detecting high-grade cervical lesions and cancer (CIN2+ and CIN3+).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the study samples collected and what endpoints were used?",{"text":117,"@type":113},"Paired FVU and clinician-collected cervical samples were collected from 286 women aged 23–64. Histological endpoints included categories from ≤CIN1 through CIN2 and CIN3/AIS and cancers.",{"name":119,"@type":110,"acceptedAnswer":120},"How did methylation testing in urine compare with extended HPV genotyping?",{"text":121,"@type":113},"No significant differences in accuracy were observed between methylation testing and extended HPV genotyping in FVU, while methylation testing showed higher sensitivity but lower specificity than HPV16/18 genotyping.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345397,1790169215,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Tranberg et al. BMC Medicine (2026) 24:308 [https://doi.org/10.1186/s12916-026-04837-5](https://doi.org/10.1186/s12916-026-04837-5)  \nBMC Medicine  \n RESEARCH Open Access  \nEvaluating DNA methylation markers  \nand extended HPV genotyping in first-void urine for detecting high-grade cervical lesions in HPV-positive women: a cross-sectional study  \nMetteTranberg1,2,3* , Severien Van Keer4, AlbertusT. Hesselink5, Pia Nørgaard2, Rikke Brøndum2, Chunsen Wu6,7, Line Winther Gustafson1,8, Anne Hammer2,9, Pinar Bor1,8, Karen Omann Binderup1,3, Christina Blach 10, Alex Vorsters4 and Renske Steenbergen11,12  \nAbstract  \nBackground First-void urine (FVU) collection for high-risk human papillomavirus (HPV) testing may reach un(der) -screened women in cervical cancer screening programs. This cross-sectional study investigated the clinical performance of DNA methylation markers ASCL1 and LHX8 in HPV-positive FVU for detecting high-grade cervical intraepithelial neoplasia and cancer (CIN2+ and CIN3+) . Additionally, results were compared with paired HPV-positive clinician-collected cervical samples (CS) and HPV genotyping.  \nMethods Paired FVU and CS samples were collected from 286 women aged 23–64 years referred for colposcopy or cervical excision. Histological endpoints included 123 ≤ CIN1 (no dysplasia and CIN1), 38 CIN2, and 123 CIN3/ AIS and 2 cancers. Samples were tested for HPV DNA andASCL1/LHX8 methylation. Methylation test performance was evaluated by area under the curve (AUC) and logistic regression. Differences between paired samples and across methylation, HPV16/18, and extended HPV16/18/31/33/52 genotyping in FVU were tested using McNemar’s test.  \nResults ASCL1 and LHX8 methylation levels in HPV-positive FVU increased significantly with disease severity. Methylation testing in FVU yielded an AUC of 0.76 (95% CI: 0 .70–0. 82) for CIN3 +and 0.73 (95% CI: 0 .67–0. 79) for CIN2 + , with sensitivities of 79 . 2%(95% CI: 71.0–85. 9%) and 75. 5%(95% CI: 68 .1–81. 9%), respectively, and a specificity of 57 . 0%(95% CI: 47 .8–65. 8%) for ≤ CIN1 . In CS, methylation testing yielded higher AUCs of 0.84 (95% CI: 0 .79–0. 89) for CIN3 + and 0.80 (95% CI: 0 .75–0. 85) for CIN2 + , with significantly higher sensitivities  \n(p ≤0. 02) but lower specificity (p = 0 . 04) than FVU. In women aged ≥ 30 years, CIN3 + sensitivity and specificity for ≤ CIN1 were similar between FVU and CS (both p = 0 . 09) . No significant differences in accuracy were observed between methylation testing and extended genotyping (p ≥0. 35) in FVU, while methylation testing showed higher sensitivity (p \u003C 0. 01) but lower specificity (p \u003C 0. 01) than HPV16/18 genotyping.  \nConclusions ASCL1/LHX8 methylation testing in HPV-positive FVU showed promise for detecting high-grade cervical disease. Its performance in FVU did not differ significantly from extended HPV genotyping and, in women  \n*Correspondence: MetteTranberg [mettrani@rm.dk](mettrani@rm.dk)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a","cbCaieJzsjgHi8hT","https://ap.wps.com/l/cbCaieJzsjgHi8hT","pdf",1114092,13,"English","# Background\n## Urinary HPV testing and triage needs\n# Methods\n## Study design and sample collection\n## Endpoints and statistical analysis\n# Results\n## Methylation performance by disease severity\n## Comparison with cervical samples and HPV genotyping\n# Conclusions\n## Clinical implications for urine-based triage","[{\"question\":\"What was the purpose of testing ASCL1 and LHX8 methylation in first-void urine?\",\"answer\":\"To evaluate the clinical performance of ASCL1 and LHX8 DNA methylation markers in HPV-positive first-void urine for detecting high-grade cervical lesions and cancer (CIN2+ and CIN3+).\"},{\"question\":\"How were the study samples collected and what endpoints were used?\",\"answer\":\"Paired FVU and clinician-collected cervical samples were collected from 286 women aged 23–64. Histological endpoints included categories from ≤CIN1 through CIN2 and CIN3/AIS and cancers.\"},{\"question\":\"How did methylation testing in urine compare with extended HPV genotyping?\",\"answer\":\"No significant differences in accuracy were observed between methylation testing and extended HPV genotyping in FVU, while methylation testing showed higher sensitivity but lower specificity than HPV16/18 genotyping.\"}]","Evaluating DNA methylation markers and extended HPV genotyping in first-void urine for detecting high-grade cervical lesions in HPV-positive women - a cross-sectional study - Abstract | PDF",1790057529,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee9719530eb1e2e590edf7d7e071222f.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9aa73c4edd7cc598fe37dfe7b465e077.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22faa5494fe24b575b79118d00aa447b.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf93027ff3fb2ce327e1430a4f691c62.webp",980,1301]